ARxIUM
PrivateLast Round
Buyout/LBO
Apr 17, 2014
Total Funding Raised
$7.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ARxIUM operates in Healthcare & Life Sciences and is based in Winnipeg. Its latest recorded funding round was a Series A round in October 2007.
ARxIUM is a medical equipment manufacturing company that provides pharmacy automation and workflow solutions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Warehouse Automation, Pharma Supply Chain, Workflow Automation
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARxIUM Comparables
Compare ARxIUM with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsa Healthcare | 86% | |
| Illinois Tool Works Inc. | 83% | |
| Omnicell, Inc. | 79% |
For institutional investors. Book with your work email.
ARxIUM Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Apr 17, 2014 | ||||
| Series A | Oct 31, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ARxIUM Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BDC Capital | Series A |
| Wellington West Capital Markets Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 137% MoM, reaching 4.9K.
- Aug 3, 2026
Open roles increased to 287, 2.6x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 29, 2026
ARxIUM announces the commercial availability of FastPak Tabletop II, a next-generation unit-dose packaging platform that improves medication safety, increases production capacity, and provides traceability, security, and operational visibility in Illinois on Oct 29th '26.
For institutional investors. Book with your work email.
ARxIUM Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ARxIUM's valuation, stock price, and market status.
Is ARxIUM a public or private company?
ARxIUM is a private company.
What is the current stock price of ARxIUM?
ARxIUM is a private company, so its shares have no public market price. Caplight tracks ARxIUM's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ARxIUM worth (valuation)?
Valuation information for ARxIUM is not publicly available.
Can I buy ARxIUM stock?
ARxIUM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ARxIUM's last funding round?
ARxIUM's most recent funding round was Buyout/LBO on April 17, 2014.
Who are the main investors in ARxIUM?
Key investors in ARxIUM include BDC Capital.
Will ARxIUM IPO soon?
No public IPO plans have been announced for ARxIUM.
How can I track ARxIUM secondary market activity?
Caplight tracks bids, offers, and trades in ARxIUM's shares on secondary markets.